A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 ...

Advances in targeted therapies, especially those targeting KRAS mutations, and cancer vaccines show promise in pancreatic ...

In early November 2025, Akeso announced a series of major developments in its oncology portfolio, including statistically significant Phase III survival results for ivonescimab in EGFR-mutated lung ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most ...

The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the effectiveness of immunotherapy in cancer patients. Widespread use of the ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...